![Crystalline forms of 3-(imidazo[1,2-b)pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt](/docs/US/2020-05-26/US10662197B2/abs.jpg.600x600.jpg)
- Patent Title: Crystalline forms of 3-(imidazo[1,2-b)pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt
-
Application No.: US16146143Application Date: 2018-09-28
-
Publication No.: US10662197B2Publication Date: 2020-05-26
- Inventor: Christopher K. Murray , Leonard W. Rozamus , John J. Chaber , Pradeep K. Sharma
- Applicant: ARIAD Pharmaceuticals, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Ariad Pharmaceuticals, Inc.
- Current Assignee: Ariad Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: C07D487/04
- IPC: C07D487/04
![Crystalline forms of 3-(imidazo[1,2-b)pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt](/abs-image/US/2020/05/26/US10662197B2/abs.jpg.150x150.jpg)
Abstract:
Novel crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide free base and 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide mono hydrochloride, pharmaceutical compositions thereof and methods of their preparation and use are disclosed herein.
Public/Granted literature
Information query
